Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
申请人:ENANTA PHARMACEUTICALS, INC.
公开号:US10457703B2
公开(公告)日:2019-10-29
The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof,
The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.
本发明提供了式 I 所代表的化合物或其药学上可接受的盐、立体异构体、溶液剂、水合物或其组合、
本发明还提供了包含这些化合物的药物组合物以及使用这些化合物治疗 FXR 介导或 TGR5 介导的疾病或病症的方法。
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
申请人:Enanta Pharmaceuticals, Inc.
公开号:EP3277286B1
公开(公告)日:2021-04-21
COMPOUNDS FOR TREATING VIRAL INFECTIONS
申请人:INSTITUT PASTEUR KOREA
公开号:US20170044181A1
公开(公告)日:2017-02-16
The present invention relates to small molecule compounds and their use in the treatment of diseases, in particular viral diseases, in particular hepatitis C virus (HCV).
US9809602B2
申请人:——
公开号:US9809602B2
公开(公告)日:2017-11-07
Sulfo-click reaction via in situ generated thioacids and its application in kinetic target-guided synthesis
作者:Niranjan Kumar Namelikonda、Roman Manetsch
DOI:10.1039/c1cc14724b
日期:——
Herein, we describe a practical, one-pot variant of the sulfo-click reaction, in which 9-fluorenylmethyl-protected thioesters are rapidly deprotected and reacted further with sulfonylazides to give N-acyl sulfonamides.